Fortrea Holdings Inc.
Fortrea Holdings Inc. (Nasdaq: FTRE) is a global contract research organization that provides clinical development services to pharmaceutical, biotechnology and medical device companies. Its offerings include Phase I–IV clinical trial management, clinical pharmacology, real-world evidence studies and consulting on… From the company’s description.
Over the twelve months to Sep 30, 2026, Fortrea Holdings Inc. reported revenue of $2.67B, down 3.4% from a year earlier, and a net loss of $68.70M. Its operating margin was 0.5%, and operations generated $201.80M in cash. In fiscal 2025, it reported revenue of $2.72B, up 1.0% from fiscal 2024, and a net loss of $986.20M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Fortrea Holdings Inc. does
In the company’s own words
Fortrea Holdings Inc. (Nasdaq: FTRE) is a global contract research organization that provides clinical development services to pharmaceutical, biotechnology and medical device companies. Its offerings include Phase I–IV clinical trial management, clinical pharmacology, real-world evidence studies and consulting on product development, regulatory strategy, market access and health economics. The company supports trials through full-service, functional service provider and hybrid delivery models, with services spanning study design, site start-up, patient recruitment, monitoring, data management, biostatistics and pharmacovigilance. Fortrea operates as one reportable segment, Clinical Services. Its clinical pharmacology work includes first-in-human and exploratory studies, supported by research units in the United Kingdom and the United States. The company’s CRO business was spun off from Labcorp in 2023; in 2024, it sold its Enabling Services operations. In fiscal 2025, Fortrea had approximately 14,300 employees and conducted operations in about 100 countries. Its website is www.fortrea.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Health Services
- Headquarters
- DURHAM, NC
- Fiscal year end
- December
- CIK
- 1965040
- SIC
- 8071
Financial performance, year by year
Fiscal 2023–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Fortrea Holdings Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Fortrea Holdings Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fortrea Holdings Inc.’s bonds, as funds hold them
Funds report holding 1 issues of Fortrea Holdings Inc.’s debt, $145.93M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 7.50%, maturing 2030 to 2030.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Fortrea Holdings Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Fortrea Holdings Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Fortrea Holdings Inc.'s last four quarterly filings that the numbers alone won't show?”